Literature DB >> 9529174

Immunosuppressants decrease neutrophil chemoattractant and attenuate ischemia/reperfusion injury of the liver in rats.

T Matsuda1, Y Yamaguchi, F Matsumura, E Akizuki, K Okabe, J Liang, H Ohshiro, O Ichiguchi, S Yamada, K Mori, M Ogawa.   

Abstract

BACKGROUND: Neutrophils may play an important role in the development of liver ischemia/reperfusion injury. We investigated the effects of the immunosuppressants azathioprine (AZA), cyclosporine A (CsA), tacrolimus (FK506), and rapamycin (RPM) on the expression of cytokine-induced neutrophil chemoattractant (CINC) after ischemia/reperfusion of the liver.
METHODS: Liver ischemia was induced in male Wistar rats by occluding the portal vein with a microvascular clip for 30 minutes. Rats received two intramuscular injections of AZA (4 mg/kg), CsA (5 mg/kg), FK506 (0.5 mg/kg), or RPM (0.5 mg/kg) 3 and 24 hours before ischemia/reperfusion of the liver.
RESULTS: Serum CINC concentrations in untreated animals increased, peaked 6 hours after reperfusion, and thereafter decreased gradually. Pretreatment with AZA, CsA, FK506, and RPM, however, inhibited the increase in serum CINC concentrations after reperfusion. CINC mRNA in liver tissue increased and peaked 3 hours after reperfusion, but was significantly lower in animals treated with AZA, CsA, FK506, and RPM. In vitro CINC production by Kupffer cells harvested from animals treated with AZA, CsA, FK506, or RPM 3 hours after reperfusion was also significantly lower than that observed in untreated animals. Both myeloperoxidase activity and the number of neutrophils accumulating in the liver 24 hours after reperfusion in animals treated with AZA, CsA, FK506, and RPM were significantly lower than in untreated animals. This correlated with lower serum aspartate transaminase, alanine transaminase, and lactate dehydrogenase levels in animals treated with AZA, CsA, FK506, and RPM 24 hours after reperfusion.
CONCLUSION: The immunosuppressants AZA, CsA, FK506, and RPM reduce neutrophil accumulation and attenuate ischemia/reperfusion injury of the liver.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529174     DOI: 10.1097/00005373-199803000-00009

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  7 in total

1.  Rapamycin protection of livers from ischemia and reperfusion injury is dependent on both autophagy induction and mammalian target of rapamycin complex 2-Akt activation.

Authors:  Jianjun Zhu; Tianfei Lu; Shi Yue; Xiuda Shen; Feng Gao; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Qiang Xia; Yuan Zhai
Journal:  Transplantation       Date:  2015-01       Impact factor: 4.939

2.  Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock.

Authors:  F Squadrito; D Altavilla; G Squadrito; M Ferlito; G M Campo; M Arlotta; S Grimaldi; C Quartarone; A Saitta; A P Caputi
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

3.  Fluorescence tomography of rapamycin-induced autophagy and cardioprotection in vivo.

Authors:  Howard H Chen; Choukri Mekkaoui; Hoonsung Cho; Soeun Ngoy; Brett Marinelli; Peter Waterman; Matthias Nahrendorf; Ronglih Liao; Lee Josephson; David E Sosnovik
Journal:  Circ Cardiovasc Imaging       Date:  2013-03-28       Impact factor: 7.792

4.  Protective effects of early CD4(+) T cell reduction in hepatic ischemia/reperfusion injury.

Authors:  Mathias Martin; Christina Mory; Andrea Prescher; Christian Wittekind; Martin Fiedler; Dirk Uhlmann
Journal:  J Gastrointest Surg       Date:  2009-11-25       Impact factor: 3.452

5.  CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury.

Authors:  Xiuda Shen; Yue Wang; Feng Gao; Feng Ren; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Yuan Zhai
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

6.  Rapamycin protects testes against germ cell apoptosis and oxidative stress induced by testicular ischemia-reperfusion.

Authors:  Morteza Ghasemnejad-Berenji; Mahmoud Ghazi-Khansari; Iraj Yazdani; Seyed Soheil Saeedi Saravi; Maliheh Nobakht; Alireza Abdollahi; Javad Mohajer Ansari; Hojjat Ghasemnejad-Berenji; Sarvin Pashapour; Ahmad Reza Dehpour
Journal:  Iran J Basic Med Sci       Date:  2017-08       Impact factor: 2.699

7.  TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.

Authors:  Hee-Seon Park; Ji-Won Song; Jin-Ho Park; Byung-Kwan Lim; Og-Sung Moon; Hwa-Young Son; Jae-Hyuk Lee; Bin Gao; Young-Suk Won; Hyo-Jung Kwon
Journal:  Autophagy       Date:  2020-11-16       Impact factor: 16.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.